[{"Assets_0_Q3_USD":4185728000.0,"EarningsPerShareBasic_1_Q3_USD":0.92,"EarningsPerShareBasic_3_Q3_USD":1.51,"EarningsPerShareDiluted_1_Q3_USD":0.91,"EarningsPerShareDiluted_3_Q3_USD":1.49,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":34531000.0,"NetIncomeLossConverted_1_Q3_USD":27393000.0,"NetIncomeLossConverted_3_Q3_USD":44841000.0,"RevenuesConverted_1_Q3_USD":535003000.0,"RevenuesConverted_3_Q3_USD":1539720000.0,"StockholdersEquity_0_Q3_USD":2848447000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":29994000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":30052000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":29660000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":29618000.0,"Ticker":"BIO","CIK":"12208","name":"BIO RAD LABORATORIES INC","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20171109"}]